Latest Healthcare News

Page 3 of 197
Alcidion has entered FY27 with record contracted revenue, a debt-free balance sheet and reaffirmed guidance for revenue and underlying EBITDA to exceed FY26. Shareholders also approved a 10-for-1 share consolidation as the healthcare software company weighs buy-backs, acquisitions and further platform investment.
Victor Sage
Victor Sage
12 Nov 2026
Cleo Diagnostics has commissioned three Ella immunoassay instruments at a US laboratory as it prepares to begin the final major clinical testing program for its pre-surgical ovarian cancer test. The approximately 1,470-sample program is intended to support a planned FDA 510(k) submission in the first half of calendar 2027, but no clinical results have yet been reported.
Ada Torres
Ada Torres
12 Nov 2026
Nanosonics has secured a second US FDA 510(k) clearance for its CORIS System, expanding the range of colonoscopes and gastroscopes eligible for reprocessing. The regulatory milestone supports planned US launch activities, although the company has not disclosed a launch date or financial forecast.
Ada Torres
Ada Torres
11 Nov 2026
Uscom Limited (ASX:UCM) reported no customer receipts and just A$2,000 in cash at 30 September, as the former medical-device business moves into a minimal-activity phase. The company is now seeking an acquisition and a possible strategic relisting.
Ada Torres
Ada Torres
11 Nov 2026
Anteris Technologies reported a wider third-quarter loss as spending accelerated on its PARADIGM heart-valve trial and manufacturing expansion. The company ended September with US$236.3 million in cash, but also retained unresolved weaknesses in financial reporting controls.
Ada Torres
Ada Torres
11 Nov 2026
Promisia Healthcare has converted sustained occupancy above 95% into a 50% rise in underlying EBITDAF, positive free cash flow and its first interim dividend. The NZX-listed aged-care operator has also raised FY27 guidance to at least NZ$9 million, although Chatswood has lifted post-acquisition leverage.
Ada Torres
Ada Torres
11 Nov 2026
Radius Health lifted first-half net profit attributable to shareholders by 27% to NZ$8.0 million and raised its interim dividend by 10% as occupancy remained strong. The aged-care operator also increased its FY27 earnings target, although debt and cash flow provide a counterweight to the upbeat result.
Ada Torres
Ada Torres
11 Nov 2026
Charles River Laboratories will pay about US$470 million in cash for Frontage’s bioanalysis and DMPK operations in Pennsylvania, with a further US$75 million tied to performance. The proposed acquisition expands Charles River’s clinical testing capabilities but will initially be neutral to non-GAAP earnings per share.
Ada Torres
Ada Torres
9 Nov 2026
Memphasys has secured its first New Zealand commercial agreement for Felix, committing a government-operated Auckland IVF clinic to a minimum of 1,200 cartridges over two years. The deal expands the device’s installed-clinic footprint, although undisclosed pricing leaves its financial contribution unclear.
Ada Torres
Ada Torres
9 Nov 2026
Biome Australia has secured an exclusive mainland China cross-border e-commerce agreement with H&S Global, targeting A$2.0 million in Year 1 purchases from an early 2027 launch. The target is larger than Biome’s entire FY26 international sales, but the company will fund 25% of Year 1 invoiced value in marketing and operational support.
Ada Torres
Ada Torres
9 Nov 2026
Humana delivered a better-than-expected third quarter on insurance claims performance, lifting its 2026 adjusted EPS guidance despite reporting an adjusted loss for the period. The company also flagged stronger CenterWell growth and a lower-cost BlackRock joint venture as part of its path towards a 3% pretax margin by 2028.
Ada Torres
Ada Torres
6 Nov 2026
Third Age Health will acquire 75% of New Zealand asbestos specialist Consultex Group for $3.75 million, adding a new Testing, Inspection & Compliance vertical. The deal will be funded through existing cash and bank debt, with settlement expected by 30 November 2026.
Victor Sage
Victor Sage
6 Nov 2026

Browse the archive

Full archive